title: Mycoplasma genitalium: An emergent sexually transmitted disease?
abstract: This article summarizes the epidemiologic evidence linking Mycoplasma genitalium to sexually transmitted disease syndromes, including male urethritis, and female cervicitis, pelvic inflammatory disease, infertility, and adverse birth outcomes. It discusses the relationship of this bacterium to human immunodeficiency virus infection and reviews the available literature on the efficacy of standard antimicrobial therapies against M genitalium.
authors.affiliation: Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: lmanhart@u.washington.edu.
authors.forename: Lisa E
authors.initials: LE
authors.lastname: Manhart
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D021821:Communicable Diseases, Emerging / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D008297:Male; D009175:Mycoplasma Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D045704:Mycoplasma genitalium; D015231:Sexually Transmitted Diseases, Bacterial / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents
keywords: Cervicitis; Mycoplasma genitalium; NGU; Pelvic inflammatory disease; STD; STI; Urethritis